Understanding LOT-CRT: Current Insights, Limitations, and Our Center's Experience
- PMID: 40364057
- PMCID: PMC12072401
- DOI: 10.3390/jcm14093025
Understanding LOT-CRT: Current Insights, Limitations, and Our Center's Experience
Abstract
Cardiac resynchronization therapy (CRT) using biventricular (BiV) pacing is the standard treatment for heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) and electrical dyssynchrony. However, one in three patients remains a non-responder. Left bundle branch area pacing (LBBAP) could represent a more physiological alternative, but its effectiveness is limited in cases of atypical left bundle branch block (LBBB) or intraventricular conduction delay (IVCD). Left Bundle Branch Pacing Optimized cardiac resynchronization therapy (LOT-CRT) integrates LBBAP with coronary sinus (CS) lead pacing to improve electrical synchrony and clinical outcomes. This review evaluates the feasibility, advantages, disadvantages, and clinical outcomes of LOT-CRT. Additionally, we describe our center's experience and propose an evidence-based implantation algorithm. A review of published studies investigating LOT-CRT was conducted, comparing its effectiveness with BiV-CRT and LBBAP alone using QRS narrowing, LVEF improvement, left ventricular remodeling, New York Heart Association (NYHA) class changes and NT-proBNP levels. It was found that LOT-CRT outperforms BiV-CRT or LBBAP alone in selected populations, at the cost of higher clinical skills, longer procedural times, and specific device setups. Randomized trials are underway to further define its role in clinical practice.
Keywords: LOT-CRT; QRS narrowing; cardiac resynchronization therapy; electrophysiology; heart failure; intraventricular conduction delay; left bundle branch pacing.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Normand C., Linde C., Blomström-Lundqvist C., Stellbrink C., Gasparini M., Anker S.D., Plummer C., Sarigul N.U., Papiashvili G., Iovev S., et al. Adherence to ESC cardiac resynchronization therapy guidelines: Findings from the ESC CRT Survey II. Europace. 2020;22:932–938. doi: 10.1093/europace/euaa067. - DOI - PubMed
-
- Herweg B., Ali R., Ilercil A., Madramootoo C., Cutro R., Weston M.W., Barold S.S. Site-specific differences in latency intervals during biventricular pacing: Impact on paced QRS morphology and echo-optimized V-V interval. Pacing Clin. Electrophysiol. 2010;33:1382–1391. doi: 10.1111/j.1540-8159.2010.02882.x. - DOI - PubMed
-
- Jastrzebski M., Wiliński J., Fijorek K., Sondej T., Czarnecka D. Mortality and morbidity in cardiac resynchronization patients: Impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome. Europace. 2013;15:258–265. doi: 10.1093/europace/eus340. - DOI - PubMed
-
- Hsu J.C., Solomon S.D., Bourgoun M., McNitt S., Goldenberg I., Klein H., Moss A.J., Foster E., MADIT-CRT Executive Committee Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) study. J. Am. Coll. Cardiol. 2012;59:2366–2373. doi: 10.1016/j.jacc.2012.01.065. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
